JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 25 No. 3 323-325
© 1984 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohta, H.
Right arrow Articles by Kuma, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohta, H.
Right arrow Articles by Kuma, K.

A New Imaging Agent for Medullary Carcinoma of the Thyroid

Hitoya Ohta, Kazutaka Yamamoto, Keigo Endo, Toru Mori, Daisaburo Hamanaka, Akira Shimazu, Katsuji Ikekubo, Kazuo Makimoto, Yasuhiro Lida, Junji Konishi, Rikushi Morita, Naotaka Hata, Kazuko Horiuchi, Akira Yokoyama, Kanji Torizuka and Kanji Kuma

Kyoto University Faculty of Medicine and Pharmaceutical Science, Kyoto, Japan
Kuma Hospital, Kobe, Japan

Correspondence: For reprints contact: Hitoya Ohta, MD, Dept. of Radiology and Nuclear Medicine, Kyoto University Hospital, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606 Japan.

ABSTRACT

Thyroid scintigraphy, using 99mTc(V) dimercaptosuccinic acid, was performed in four patients with pathologically confirmed medullary thyroid carcinoma and elevated serum calcitonin values. Significant uptake of the tracer was found in the clinically palpable cervical tumor masses, metastatic sites, and residual tumor. This finding, probably specific for medullary thyroid carcinoma, could be of great use in the diagnosis and the surgical follow-up.




This article has been cited by other articles:


Home page
 Br. J. Radiol.Home page
S Basu, N Nair, S Awasare, B P Tiwari, R Asopa, and C Nair
99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications
Br. J. Radiol., April 1, 2004; 77(916): 347 - 361.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Massardo, O. Alonso, L. Kabasakal, A. Llamas-Olier, U. R. Shankar, H. Zhu, L. Delgado, P. Gonzalez, F. Mut, and A. K. Padhy
Diagnostic Value of 99mTc-Methylene Diphosphonate and 99mTc-Pentavalent DMSA Compared with 99mTc-Sestamibi for Palpable Breast Lesions
J. Nucl. Med., July 1, 2002; 43(7): 882 - 888.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
B.-F. Lee, N.-T. Chiu, D.-C. Wu, K.-B. Tsai, G.-C. Liu, H.-S. Yu, and S.-T. Wang
Use of 99mTc (V) DMSA Scintigraphy in the Detection and Localization of Intestinal Inflammation: Comparison of Findings at Colonoscopy and Biopsy
Radiology, August 1, 2001; 220(2): 381 - 385.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1984 by the Society of Nuclear Medicine.